These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
389 related articles for article (PubMed ID: 19609263)
1. Exploiting and antagonizing microRNA regulation for therapeutic and experimental applications. Brown BD; Naldini L Nat Rev Genet; 2009 Aug; 10(8):578-85. PubMed ID: 19609263 [TBL] [Abstract][Full Text] [Related]
2. MicroRNAs as targets for antisense-based therapeutics. Stenvang J; Kauppinen S Expert Opin Biol Ther; 2008 Jan; 8(1):59-81. PubMed ID: 18081537 [TBL] [Abstract][Full Text] [Related]
3. microRNA inhibitors: Natural and artificial sequestration of microRNA. Tang L; Chen HY; Hao NB; Tang B; Guo H; Yong X; Dong H; Yang SM Cancer Lett; 2017 Oct; 407():139-147. PubMed ID: 28602827 [TBL] [Abstract][Full Text] [Related]
4. The promise of microRNA replacement therapy. Bader AG; Brown D; Winkler M Cancer Res; 2010 Sep; 70(18):7027-30. PubMed ID: 20807816 [TBL] [Abstract][Full Text] [Related]
6. microRNAs as pharmacological targets in cancer. Soriano A; Jubierre L; Almazán-Moga A; Molist C; Roma J; de Toledo JS; Gallego S; Segura MF Pharmacol Res; 2013 Sep; 75():3-14. PubMed ID: 23537752 [TBL] [Abstract][Full Text] [Related]
7. Development of Novel Therapeutic Agents by Inhibition of Oncogenic MicroRNAs. Nguyen DD; Chang S Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29280958 [TBL] [Abstract][Full Text] [Related]
8. MicroRNAs-based Therapy: A Novel and Promising Strategy for Cancer Treatment. Moles R Microrna; 2017 Aug; 6(2):102-109. PubMed ID: 28699479 [TBL] [Abstract][Full Text] [Related]
9. Using artificial microRNA sponges to achieve microRNA loss-of-function in cancer cells. Tay FC; Lim JK; Zhu H; Hin LC; Wang S Adv Drug Deliv Rev; 2015 Jan; 81():117-27. PubMed ID: 24859534 [TBL] [Abstract][Full Text] [Related]
10. Strategies to use microRNAs as therapeutic targets. Krützfeldt J Best Pract Res Clin Endocrinol Metab; 2016 Oct; 30(5):551-561. PubMed ID: 27923450 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic microRNA strategies in human cancer. Li C; Feng Y; Coukos G; Zhang L AAPS J; 2009 Dec; 11(4):747-57. PubMed ID: 19876744 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA: potential targets for the development of novel drugs? Wu W Drugs R D; 2010; 10(1):1-8. PubMed ID: 20509710 [TBL] [Abstract][Full Text] [Related]
13. Recent trends in targeting miRNAs for cancer therapy. Shah V; Shah J J Pharm Pharmacol; 2020 Dec; 72(12):1732-1749. PubMed ID: 32783235 [TBL] [Abstract][Full Text] [Related]
14. Generation of Efficient miRNA Inhibitors Using Tough Decoy Constructs. Yoo J; Hajjar RJ; Jeong D Methods Mol Biol; 2017; 1521():41-53. PubMed ID: 27910040 [TBL] [Abstract][Full Text] [Related]
15. MicroRNAs as cancer players: potential clinical and biological effects. Bandres E; Agirre X; Ramirez N; Zarate R; Garcia-Foncillas J DNA Cell Biol; 2007 May; 26(5):273-82. PubMed ID: 17504023 [TBL] [Abstract][Full Text] [Related]
16. Machine learning-based identification of endogenous cellular microRNA sponges against viral microRNAs. Kang S; Park S; Yoon S; Min H Methods; 2017 Oct; 129():33-40. PubMed ID: 28323040 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-based therapeutics for cancer. Wang V; Wu W BioDrugs; 2009; 23(1):15-23. PubMed ID: 19344188 [TBL] [Abstract][Full Text] [Related]
18. Construction of Multi-Potent MicroRNA Sponge and Its Functional Evaluation. Chang S Methods Mol Biol; 2018; 1699():201-209. PubMed ID: 29086379 [TBL] [Abstract][Full Text] [Related]